Trump migrant detentions at Guantanamo Bay cost $100,000 per person daily, senator says
President Donald Trump's use of the Guantanamo Bay naval base to house migrants appears to cost $100,000 per day for each detainee, U.S. Senator Gary Peters said during a hearing on Tuesday, decrying what he described as a prime example of wasteful government spending.
Peters, the top Democrat on the Senate Homeland Security and Governmental Affairs Committee, questioned Homeland Security Secretary Kristi Noem about the high cost, far more than the $165 per day in U.S. immigration detention facilities. Peters also asked why detainees have been sent to the American naval base in Cuba but then shuttled back to the United States at taxpayer expense.
'We're spending $100,000 a day to keep someone at Guantanamo,' Peters said. 'We keep them there awhile, then we fly them back to the United States, or we could keep them here for $165 a day. I think that's kind of outrageous.'
The White House has requested a huge increase in funding for immigration enforcement as it tries to achieve Trump's goal of mass deportations. The administration asked Congress this month for an additional $44-billion for the Department of Homeland Security in fiscal year 2026, which begins on Oct. 1.
Noem, appearing before the committee to defend the budget request, said she did not know the daily cost to house migrants at Guantanamo Bay. Her department did not immediately respond to a request for comment.
A U.S. official, speaking on condition of anonymity, said there were roughly 70 migrants currently detained there.
The American Civil Liberties Union filed a lawsuit in March to prevent 10 migrants from being transferred to the base. In the suit, ACLU alleged that migrants at Guantanamo had been held in windowless rooms for at least 23 hours per day, subjected to invasive strip searches, and unable to contact family members. Some had attempted suicide, the ACLU said.
Senator Rand Paul, the Republican chairman of the committee, also raised concerns with spending for additional barriers at the U.S.-Mexico border since the number of migrants caught crossing illegally has plummeted since Trump took office. A sweeping U.S. House of Representatives budget plan would devote $46.5-billion to the border wall alone.
'I'm not saying no new money is needed,' Paul said. 'I think you need more Border Patrol, and you're going to need more money for that, but I think it should be within reason.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
38 minutes ago
- National Post
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 2030
Article content CHICAGO — Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative financing approaches to manage the costs of treatment and care. Article content 'Despite CAR T-cell therapy being available in the United States for nearly seven years in large B-cell lymphoma, only approximately two out of 10 eligible patients with some advanced blood cancers ever receive CAR T-cell therapy,' said Miguel Perales, MD, Chief, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center (MSK); Past President, American Society for Transplantation and Cellular Therapy (ASTCT); and Co-Chair, CAR T Vision Steering Committee. 'When it comes to treating these potentially deadly cancers, every minute counts. That is why we established CAR T Vision with recommendations for interventions that, when adopted and scaled, will help many more eligible patients get the opportunity for cure within the next five years.' Article content The roadmap report, developed by an independent Steering Committee comprised of leadership from top North American and European patient advocacy groups, medical society organizations, academic and community treatment centers, health technology assessment, policy, and other subject matter experts, provides the foundations for advocacy and action by local stakeholders to address the specific access challenges patients face in different geographies. Building on the report, expert Working Groups will be established to translate the Vision into concrete, measurable actions, including specific recommendations and a measurement framework to track progress. Article content 'Limited awareness of CAR T-cell therapy, low referrals, hospital capacity challenges, and funding and reimbursement are among the barriers that either prevent people from accessing CAR T-cell therapy altogether or cause delays that advance a patient's cancer beyond the point of treatment eligibility. In short, these barriers cost lives,' said Anna Sureda, MD, PhD, Clinical Hematologist, Professor and Cell Therapy Researcher; and Co-Chair, CAR T Vision Steering Committee. 'We call on every stakeholder and organization with the ability to help shape better patient outcomes—policymakers, health system leaders, payors, healthcare providers, patient advocates, and industry—to join the growing coalition of Vision endorsers and help ensure every eligible patient has the opportunity for cure with CAR T-cell therapy.' Article content Making CAR T Vision a reality will require the coming together of a complex ecosystem of partners, each with their own unique role to play. To learn more about CAR T Vision, review the roadmap report and join the coalition, visit Article content CAR T-cell therapy involves engineering a person's own immune cells to target and treat cancer and is currently approved for certain types of aggressive blood cancers, enabling some patients to remain cancer free for more than five years. 4,5,6,7 Article content The CAR T Vision is for every eligible patient to have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. The CAR T Vision Steering Committee includes leadership from top North American and European patient advocacy groups, medical society organizations, academic and community treatment centers, health technology assessment, policy, and other subject matter experts. The new roadmap report details the challenges CAR T Vision aims to resolve through multidisciplinary collaboration and the urgent actions needed to make the Vision a reality. The report and initial activities of the CAR T Vision Steering Committee have been funded by Gilead Sciences and Kite, as the inaugural supporter of CAR T Vision. Report content has been reviewed by Gilead Sciences and Kite. However, the Steering Committee has editorial control of the CAR T Vision and its outputs, including the report. Dr. Perales has financial interests related to Gilead Sciences and Kite. To learn more about CAR T Vision, review the report and join the growing coalition of endorsers, visit Article content 2 Chuhara, D, Liao, L, et al. Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma. Blood. 2023, September 21. Article content 3 Canales Albendea MÁ, Canonico PL, Cartron G, et al. Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries. Front Med (Lausanne). 2023;10:1128295. Published 2023 May 30. doi:10.3389/fmed.2023.1128295 Article content 4 Abramson J, Palomba ML, Gordon LI, et al. Five-Year Survival of Patients (pts) from Transcend NHL 001 (TRANSCEND) Supports Curative Potential of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL). Blood. 2024;144(1):3125. Article content 5 Neelapu SS, Jacobson CA, Ghobadi A, et al. Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma. Blood. 2023 May 11;141(19):2307-2315. doi: 10.1182/blood.2022018893. PMID: 36821768; PMCID: PMC10646788. Article content 6 Rives S, Maude S, Hiramatsu H et al. S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY. HemaSphere 6():p 13-14, June 2022. | DOI: 10.1097/ Article content Article content Article content Article content Article content Article content
Toronto Star
an hour ago
- Toronto Star
A shocking homicide investigation + Inside Prime Minister Mark Carney's rise to leadership
Good morning. This is the Friday, May 30 edition of First Up, the Star's daily morning digest. Sign up to get it earlier each day, in your inbox. Here's the latest on the arrest of a 13-year-old boy following a homicide in Durham and part two of a Star exclusive series reviewing Mark Carney's unexpected rise to leadership. Also, raging wildfires in Manitoba have made their way to Saskatchewan. Here's what we know. ARTICLE CONTINUES BELOW DON'T MISS Police arrested a 13-year-old boy after investigating a Durham homicide The arrest followed a manhunt and request to shelter in place. Here's what we know. 'We pray for all involved,' family of Mario Bilich says as judge finds accused triple murderer mentally unfit to stand trial A secret confession, chartered flights and strip searches: Behind the scenes of the girls-swarming saga after the killing of Kenneth Lee Mark Carney was already 'Mr. Business' when Trump upended the race With Carney as the front-runner, the Conservatives shifted their message. Here's what happened next. Inside the 2025 election: How Mark Carney resurrected the Liberal party with Pierre Poilievre's help The Star named Toronto's top influencers of 2025 These GTA creators are a representation of Toronto's culture. Find out who made the list. The making of a list: Behind the scenes of the Toronto Star's top 24 influencers of 2024 Toronto's Top 24 of 2024 WHAT ELSE Darrell Brown announces the five inductees into the CNE's inaugural food hall of fame in August 2024. Richard Lautens/ Toronto Star File Photo CNE fired its CEO and his wife. They call the harassment allegations against them 'unjust.' One of the girls in the swarming case will learn whether she is guilty of murder this afternoon. Here's what we know. Small businesses have been scrambling for alternatives during the Canada Post chaos. Here's what they've found. Experts predict big challenges for this Chinese billionaire to execute her plan for 28 Hudson's Bay leases. Here's why. A 'secret' memo revealed how Canada's refusal to join this missile system in 2005 hurt its reputation. Andrew Phillips: Trump's attacks on Canada won't stop. Here's how to avoid his traps. The Star's Ottawa bureau broke down the start of Carney's first term as an elected prime minister. Listen here. This Toronto Grammy-nominated musician opened a sandwich shop. Take a look at what they're serving. Gregor Chisholm: How the Blue Jays rotation plays with fire but rarely gets burned. Doug Smith: Here's why Collin Murray-Boyles gets compared to Draymond Green but is a risk for Toronto. POV Toronto's old-fashioned — but effective — way to ease traffic jams has one serious flaw. CLOSE UP Edmonton Oilers pose for photos after winning Game 5 of the Western Conference finals against the Dallas Stars in the NHL hockey Stanley Cup playoffs, Thursday, May 29, 2025, in Dallas. Julio Cortez/AP DALLAS: The Edmonton Oilers will advance to the NHL Stanley Cup finals after a 6-3 win in Game 5 of the Western Conference finals against the Dallas Stars. Here's how it all went down. Thank you for reading. You can reach me and the First Up team at firstup@ I will see you back here tomorrow. Sign up here to get this newsletter in your inbox.
CTV News
an hour ago
- CTV News
Google, U.S. Justice Department face off in climactic showdown in search monopoly case
Google will return to federal court Friday to fend off the U.S. Justice Department's attempt to topple its internet empire at the same time it's navigating a pivotal shift to artificial intelligence that could undercut its power. The legal and technological threats facing Google are among the key issues that will be dissected during the closing arguments of a legal proceeding that will determine the changes imposed upon the company in the wake of its dominant search engine being declared as an illegal monopoly by U.S. District Judge Amit Mehta last year. Brandishing evidence presented during a recent three-week stretch of hearings, Justice Department lawyers will attempt to persuade Mehta to order a radical shake-up that includes a ban on Google paying to lock its search engine in as the default on smart devices and an order requiring the company to sell its Chrome browser. Google lawyers are expected to assert only minor concessions are needed, especially as the upheaval triggered by advances in artificial intelligence already are reshaping the search landscape, as alternative, conversational search options are rolling out from AI startups that are hoping to use the Department of Justice's four-and-half-year-old case to gain the upper hand in the next technological frontier. 'Over weeks of testimony, we heard from a series of well-funded companies eager to gain access to Google's technology so they don't have to innovate themselves,' Lee-Anne Mulholland, Google's vice president of regulatory affairs, wrote in a blog post earlier this month. 'What we didn't hear was how DOJ's extreme proposals would benefit consumers.' After the day-long closing arguments, Mehta will spend much of the summer mulling a decision that he plans to issue before Labor Day. Google has already vowed to appeal the ruling that branded its search engine as a monopoly, a step it can't take until the judge orders a remedy. While both sides of this showdown agree that AI is an inflection point for the industry's future, they have disparate views on how the shift will affect Google. The Justice Department contends that AI technology by itself won't rein in Google's power, arguing additional legal restraints must be slapped on a search engine that's the main reason its parent company, Alphabet Inc., is valued at $2 trillion. Google has already been deploying AI to transform its search engine i nto an answer engine, an effort that has so far helped maintain its perch as the internet's main gateway despite inroads being made by alternatives from the likes of OpenAI and Perplexity. The Justice Department contends a divestiture of the Chrome browser that Google CEO Sundar Pichai helped build nearly 20 years ago would be among the most effective countermeasures against Google continuing to amass massive volumes of browser traffic and personal data that could be leveraged to retain its dominance in the AI era. Executives from both OpenAi and Perplexity testified last month that they would be eager bidders for the Chrome browser if Mehta orders its sale. The debate over Google's fate also has pulled in opinions from Apple, mobile app developers, legal scholars and startups. Apple, which collects more than $20 billion annually to make Google the default search engine on the iPhone and its other devices, filed briefs arguing against the Justice Department's proposed 10-year ban on such lucrative lock-in agreements. Apple told the judge that prohibiting the contracts would deprive the company of money that it funnels into its own research, and that the ban might even make Google even more powerful because the company would be able to hold onto its money while consumers would end up choosing its search engine anyway. The Cupertino, California, company also told the judge a ban wouldn't compel it to build its own search engine to compete against Google. In other filings, a group of legal scholars said the Justice Department's proposed divestiture of Chrome would be an improper penalty that would inject unwarranted government interference in a company's business. Meanwhile, former Federal Trade Commission officials James Cooper and Andrew Stivers warned that another proposal that would require Google to share its data with rival search engines 'does not account for the expectations users have developed over time regarding the privacy, security, and stewardship' of their personal information. The App Association, a group that represents mostly small software developers, also advised Mehta not to adopt the Justice Department's proposed changes because of the ripple effects they would have across the tech industry. Hobbling Google in the way the Justice Department envisions would make it more difficult for startups to realize their goal of being acquired, the App Association wrote. 'Developers will be overcome by uncertainty' if Google is torn apart, the group argues. Buy Y Combinator, an incubator that has helped create hundreds of startups collectively worth about $800 billion filed documents pushing for the dramatic overhaul of Google, whose immense power has discouraged venture capitalists from investing in areas that are considered to be part of the company's 'kill zone.' Startups 'also need to be able to get their products into the hands of users, free from restrictive dealing and self-preferencing that locks up important distribution channels. As things stand, Google has locked up the most critical distribution channels, freezing the general search and search text advertising markets into static competition for more than a decade,' Y Combinator told Mehta. Michael Liedtke, The Associated Press
